Holland & Barrett has reinstated around 30 CBD products that it temporarily withdrew from sale after the Food Standards Agency issued new advice on acceptable daily intake of CBD (cutting the earlier ADI sevenfold, to 10mg).
The reinstatement of products follows an internal review and assessment of the new guidance by the retailer and its advisers.
In a statement, the company said: “As a responsible retailer we always act with our customers’ best interests at heart, which is why we temporarily removed some products from sale while our science, legal and independent advisors assessed the new guidance from the FSA. We wanted to make sure we could help customers make an informed choice on what dosage and for how long they take CBD for.
“In line with the FSA’s direction, we have now developed advisory guidance, training for colleagues, online advice and information at shelf edge, meaning that customers can access the information they need when choosing which strength is right for them. We are committed to working with the FSA and the wider industry for the benefit of our customers as the CBD market continues to develop. We would like to thank our suppliers for their support while we completed this review.”